VRCA · Verrica Pharmaceuticals Inc. · Executive Compensation
$3.56
-0.16 (-4.30%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current business plan and current capital resources, combined with the uncertainty regarding the availability of additional funding, we have concluded that there is substantial doubt regarding our ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”View the 10-Q filed Nov 13, 2026
Market Cap
$61.16M
Shares
17.18M
Volume · Nov 13
18.68K
Avg daily vol (3M)
72.22K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Christopher G. Hayes | Former Chief Legal Officer | $747,579 |
| Jayson Rieger | President and Chief Executive Officer | $741,403 |
| John J. Kirby | Interim Chief Financial Officer | $614,600 |
| Gary Goldenberg | Former Chief Medical Officer | $363,127 |
| Noah Rosenberg | Chief Medical Officer | $347,588 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Ted White | Former President and Chief Executive Officer | $2,594,832 |
| Joe Bonaccorso | Former Chief Commercial Officer | $1,279,038 |
| Jayson Rieger | President and Chief Executive Officer | $1,236,225 |
| Christopher G. Hayes | Chief Legal Officer | $1,028,062 |
| Gary Goldenberg | Former Chief Medical Officer | $973,317 |
| John J. Kirby | Interim Chief Financial Officer | $114,587 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Ted White | Former President and Chief Executive Officer | $3,504,647 |
| Christopher G. Hayes | Chief Legal Officer | $2,561,674 |
| Joe Bonaccorso | Former Chief Commercial Officer | $2,097,472 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Ted White | President, Chief Executive Officer and Director | $1,935,834 |
| Joe Bonaccorso | Chief Commercial Officer | $986,518 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Joe Bonaccorso | Chief Commercial Officer | $1,224,333 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Ted White | President, Chief Executive Officer and Director | $1,706,704 |
| Gary Goldenberg | Chief Medical Officer | $1,514,036 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Ted White | President, Chief Executive Officer and Director | $1,441,189 |
| A. Brian Davis | Chief FinancialOfficer | $1,339,581 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Lawrence Eichenfield | director | Appointed | 2026-06-09 |
| Paul B. Manning | director | Appointed | 2026-06-09 |
| Charles Frantzreb | director | Appointed | 2025-12-30 |
| Christopher G. Hayes | Chief Legal Officer, Chief Compliance Officer and Corporate Secretary | Resigned | 2025-04-25 |
| Gavin Corcoran | director | Appointed | 2025-04-02 |
| David Zawitz | Chief Operating Officer and Principal Operating Officer | Appointed | 2024-12-09 |
| John Kirby | interim Chief Financial Officer | Appointed | 2024-11-04 |
| Jayson Rieger | director | Appointed | 2024-11-04 |
| Jayson Rieger | President and Chief Executive Officer | Appointed | 2024-11-04 |
| John Kirby | Interim Chief Financial Officer | Appointed | 2024-11-04 |
| Jayson Rieger | Chief Executive Officer | Appointed | 2024-11-04 |
| John J. Kirby | Interim Chief Financial Officer | Appointed | 2024-11-04 |
| Dr. Jayson Rieger | member of the Board | Appointed | 2024-11-04 |
| Dr. Jayson Rieger | President, Chief Executive Officer, and as member of the Board | Appointed | 2024-11-04 |
| Ted White | member of the Company's Board of Directors | Resigned | 2024-11-04 |
| Ted White | President and Chief Executive Officer | Resigned | 2024-11-04 |
| Craig Ballaron | member of the Board of Directors | Resigned | 2024-10-08 |
| Terence Kohler | Chief Financial Officer | Resigned | 2024-09-27 |
| Joe Bonaccorso | Chief Commercial Officer | Resigned | 2024-08-27 |
Leadership
- Dr. Jayson Rieger CEO, Board Member
- Jayson Rieger CEO, Board Member
- John J. Kirby CFO
- John Kirby CFO
- Terry Kohler CFO, Chief Accounting Officer
- David Zawitz COO
- Charles Frantzreb Board Member
- Diem Nguyen Board Member
- Gavin Corcoran Board Member
- Lawrence Eichenfield Board Member
- Paul B. Manning Board Member
Key facts
CIK
1660334
CUSIP
92511W207
13F (30d)
46 filings
25 filers
Visit website
Investor relations